[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Drug Metabolism and Pharmacokinetics (DMPK) Market Growth (Status and Outlook) 2024-2030

May 2024 | 127 pages | ID: GD4A4B7D6AE7EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

DMPK is an acronym that stands for drug metabolism and pharmacokinetics. This is a discipline that helps to identify drugs that are likely to be suitable for advancement through the drug development process. It considers how the drug is metabolized and processed by the body.

The global Drug Metabolism and Pharmacokinetics (DMPK) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Drug Metabolism and Pharmacokinetics (DMPK) Industry Forecast” looks at past sales and reviews total world Drug Metabolism and Pharmacokinetics (DMPK) sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Metabolism and Pharmacokinetics (DMPK) sales for 2023 through 2029. With Drug Metabolism and Pharmacokinetics (DMPK) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Metabolism and Pharmacokinetics (DMPK) industry.

This Insight Report provides a comprehensive analysis of the global Drug Metabolism and Pharmacokinetics (DMPK) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Metabolism and Pharmacokinetics (DMPK) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Metabolism and Pharmacokinetics (DMPK) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Metabolism and Pharmacokinetics (DMPK) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Metabolism and Pharmacokinetics (DMPK).

United States market for Drug Metabolism and Pharmacokinetics (DMPK) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Drug Metabolism and Pharmacokinetics (DMPK) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Drug Metabolism and Pharmacokinetics (DMPK) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Drug Metabolism and Pharmacokinetics (DMPK) players cover Eurofins Discovery, Inotiv, Evotec, Sai Life Sciences, Sygnature Discovery, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Metabolism and Pharmacokinetics (DMPK) market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Small Molecules
  • Biologics
Segmentation by Application:
  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
Segmentation by Type:
  • Small Molecules
  • Biologics
Segmentation by Application:
  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Eurofins Discovery
  • Inotiv
  • Evotec
  • Sai Life Sciences
  • Sygnature Discovery
  • WuXi AppTec
  • Hangzhou Tigermed Consulting Co
  • Q2 Solutions
  • Jubilant Biosys
  • Frontage Laboratories
  • Invitrocue
  • Creative Biolabs
  • CrownBioscience
  • Agilent
  • H3D
  • LABCORP
  • Bioduro-Sundia
  • Allucent
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2019-2030
  2.1.2 Drug Metabolism and Pharmacokinetics (DMPK) Market Size CAGR by Region (2019 VS 2023 VS 2030)
  2.1.3 World Current & Future Analysis for Drug Metabolism and Pharmacokinetics (DMPK) by Country/Region, 2019, 2023 & 2030
2.2 Drug Metabolism and Pharmacokinetics (DMPK) Segment by Type
  2.2.1 Small Molecules
  2.2.2 Biologics
2.3 Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type
  2.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Type (2019-2024)
2.4 Drug Metabolism and Pharmacokinetics (DMPK) Segment by Application
  2.4.1 Biopharmaceutical Companies
  2.4.2 Government and Academic Institutes
  2.4.3 Others
2.5 Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application
  2.5.1 Drug Metabolism and Pharmacokinetics (DMPK) Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Application (2019-2024)

3 DRUG METABOLISM AND PHARMACOKINETICS (DMPK) MARKET SIZE BY PLAYER

3.1 Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Player
  3.1.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Player (2019-2024)
  3.1.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Player (2019-2024)
3.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 DRUG METABOLISM AND PHARMACOKINETICS (DMPK) BY REGION

4.1 Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2019-2024)
4.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth (2019-2024)
4.4 APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth (2019-2024)
4.5 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth (2019-2024)
4.6 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024)
5.2 Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2019-2024)
5.3 Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2019-2024)
6.2 APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2019-2024)
6.3 APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024)
7.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2019-2024)
7.3 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) by Region (2019-2024)
8.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2019-2024)
8.3 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL DRUG METABOLISM AND PHARMACOKINETICS (DMPK) MARKET FORECAST

10.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Forecast by Region (2025-2030)
  10.1.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Forecast by Region (2025-2030)
  10.1.2 Americas Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.1.3 APAC Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.1.4 Europe Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.1.5 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Forecast
10.2 Americas Drug Metabolism and Pharmacokinetics (DMPK) Forecast by Country (2025-2030)
  10.2.1 United States Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.2.2 Canada Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.2.3 Mexico Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.2.4 Brazil Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
10.3 APAC Drug Metabolism and Pharmacokinetics (DMPK) Forecast by Region (2025-2030)
  10.3.1 China Drug Metabolism and Pharmacokinetics (DMPK) Market Forecast
  10.3.2 Japan Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.3.3 Korea Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.3.4 Southeast Asia Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.3.5 India Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.3.6 Australia Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
10.4 Europe Drug Metabolism and Pharmacokinetics (DMPK) Forecast by Country (2025-2030)
  10.4.1 Germany Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.4.2 France Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.4.3 UK Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.4.4 Italy Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.4.5 Russia Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
10.5 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Forecast by Region (2025-2030)
  10.5.1 Egypt Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.5.2 South Africa Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.5.3 Israel Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
  10.5.4 Turkey Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast
10.6 Global Drug Metabolism and Pharmacokinetics (DMPK) Forecast by Type (2025-2030)
10.7 Global Drug Metabolism and Pharmacokinetics (DMPK) Forecast by Application (2025-2030)
  10.7.1 GCC Countries Market Drug Metabolism and Pharmacokinetics (DMPK) Forecast

11 KEY PLAYERS ANALYSIS

11.1 Eurofins Discovery
  11.1.1 Eurofins Discovery Company Information
  11.1.2 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.1.3 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Eurofins Discovery Main Business Overview
  11.1.5 Eurofins Discovery Latest Developments
11.2 Inotiv
  11.2.1 Inotiv Company Information
  11.2.2 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.2.3 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Inotiv Main Business Overview
  11.2.5 Inotiv Latest Developments
11.3 Evotec
  11.3.1 Evotec Company Information
  11.3.2 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.3.3 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Evotec Main Business Overview
  11.3.5 Evotec Latest Developments
11.4 Sai Life Sciences
  11.4.1 Sai Life Sciences Company Information
  11.4.2 Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.4.3 Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Sai Life Sciences Main Business Overview
  11.4.5 Sai Life Sciences Latest Developments
11.5 Sygnature Discovery
  11.5.1 Sygnature Discovery Company Information
  11.5.2 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.5.3 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Sygnature Discovery Main Business Overview
  11.5.5 Sygnature Discovery Latest Developments
11.6 WuXi AppTec
  11.6.1 WuXi AppTec Company Information
  11.6.2 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.6.3 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 WuXi AppTec Main Business Overview
  11.6.5 WuXi AppTec Latest Developments
11.7 Hangzhou Tigermed Consulting Co
  11.7.1 Hangzhou Tigermed Consulting Co Company Information
  11.7.2 Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.7.3 Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Hangzhou Tigermed Consulting Co Main Business Overview
  11.7.5 Hangzhou Tigermed Consulting Co Latest Developments
11.8 Q2 Solutions
  11.8.1 Q2 Solutions Company Information
  11.8.2 Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.8.3 Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Q2 Solutions Main Business Overview
  11.8.5 Q2 Solutions Latest Developments
11.9 Jubilant Biosys
  11.9.1 Jubilant Biosys Company Information
  11.9.2 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.9.3 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Jubilant Biosys Main Business Overview
  11.9.5 Jubilant Biosys Latest Developments
11.10 Frontage Laboratories
  11.10.1 Frontage Laboratories Company Information
  11.10.2 Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.10.3 Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Frontage Laboratories Main Business Overview
  11.10.5 Frontage Laboratories Latest Developments
11.11 Invitrocue
  11.11.1 Invitrocue Company Information
  11.11.2 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.11.3 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Invitrocue Main Business Overview
  11.11.5 Invitrocue Latest Developments
11.12 Creative Biolabs
  11.12.1 Creative Biolabs Company Information
  11.12.2 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.12.3 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Creative Biolabs Main Business Overview
  11.12.5 Creative Biolabs Latest Developments
11.13 CrownBioscience
  11.13.1 CrownBioscience Company Information
  11.13.2 CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.13.3 CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.13.4 CrownBioscience Main Business Overview
  11.13.5 CrownBioscience Latest Developments
11.14 Agilent
  11.14.1 Agilent Company Information
  11.14.2 Agilent Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.14.3 Agilent Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.14.4 Agilent Main Business Overview
  11.14.5 Agilent Latest Developments
11.15 H3D
  11.15.1 H3D Company Information
  11.15.2 H3D Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.15.3 H3D Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.15.4 H3D Main Business Overview
  11.15.5 H3D Latest Developments
11.16 LABCORP
  11.16.1 LABCORP Company Information
  11.16.2 LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.16.3 LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.16.4 LABCORP Main Business Overview
  11.16.5 LABCORP Latest Developments
11.17 Bioduro-Sundia
  11.17.1 Bioduro-Sundia Company Information
  11.17.2 Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.17.3 Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.17.4 Bioduro-Sundia Main Business Overview
  11.17.5 Bioduro-Sundia Latest Developments
11.18 Allucent
  11.18.1 Allucent Company Information
  11.18.2 Allucent Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
  11.18.3 Allucent Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
  11.18.4 Allucent Main Business Overview
  11.18.5 Allucent Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Drug Metabolism and Pharmacokinetics (DMPK) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Drug Metabolism and Pharmacokinetics (DMPK) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Small Molecules
Table 4. Major Players of Biologics
Table 5. Drug Metabolism and Pharmacokinetics (DMPK) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2019-2024) & ($ millions)
Table 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Type (2019-2024)
Table 8. Drug Metabolism and Pharmacokinetics (DMPK) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2024) & ($ millions)
Table 10. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Application (2019-2024)
Table 11. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Player (2019-2024) & ($ millions)
Table 12. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Player (2019-2024)
Table 13. Drug Metabolism and Pharmacokinetics (DMPK) Key Players Head office and Products Offered
Table 14. Drug Metabolism and Pharmacokinetics (DMPK) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2019-2024) & ($ millions)
Table 18. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Region (2019-2024)
Table 19. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Country (2019-2024)
Table 23. Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Type (2019-2024)
Table 25. Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Application (2019-2024)
Table 27. APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Region (2019-2024)
Table 29. APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Country (2019-2024)
Table 33. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Drug Metabolism and Pharmacokinetics (DMPK)
Table 39. Key Market Challenges & Risks of Drug Metabolism and Pharmacokinetics (DMPK)
Table 40. Key Industry Trends of Drug Metabolism and Pharmacokinetics (DMPK)
Table 41. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. Eurofins Discovery Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 46. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 47. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. Eurofins Discovery Main Business
Table 49. Eurofins Discovery Latest Developments
Table 50. Inotiv Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 51. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 52. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Inotiv Main Business
Table 54. Inotiv Latest Developments
Table 55. Evotec Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 56. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 57. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Evotec Main Business
Table 59. Evotec Latest Developments
Table 60. Sai Life Sciences Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 61. Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 62. Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Sai Life Sciences Main Business
Table 64. Sai Life Sciences Latest Developments
Table 65. Sygnature Discovery Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 66. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 67. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Sygnature Discovery Main Business
Table 69. Sygnature Discovery Latest Developments
Table 70. WuXi AppTec Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 71. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 72. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. WuXi AppTec Main Business
Table 74. WuXi AppTec Latest Developments
Table 75. Hangzhou Tigermed Consulting Co Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 76. Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 77. Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Hangzhou Tigermed Consulting Co Main Business
Table 79. Hangzhou Tigermed Consulting Co Latest Developments
Table 80. Q2 Solutions Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 81. Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 82. Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Q2 Solutions Main Business
Table 84. Q2 Solutions Latest Developments
Table 85. Jubilant Biosys Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 86. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 87. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Jubilant Biosys Main Business
Table 89. Jubilant Biosys Latest Developments
Table 90. Frontage Laboratories Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 91. Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 92. Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Frontage Laboratories Main Business
Table 94. Frontage Laboratories Latest Developments
Table 95. Invitrocue Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 96. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 97. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Invitrocue Main Business
Table 99. Invitrocue Latest Developments
Table 100. Creative Biolabs Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 101. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 102. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Creative Biolabs Main Business
Table 104. Creative Biolabs Latest Developments
Table 105. CrownBioscience Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 106. CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 107. CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. CrownBioscience Main Business
Table 109. CrownBioscience Latest Developments
Table 110. Agilent Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 111. Agilent Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 112. Agilent Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Agilent Main Business
Table 114. Agilent Latest Developments
Table 115. H3D Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 116. H3D Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 117. H3D Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. H3D Main Business
Table 119. H3D Latest Developments
Table 120. LABCORP Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 121. LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 122. LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. LABCORP Main Business
Table 124. LABCORP Latest Developments
Table 125. Bioduro-Sundia Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 126. Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 127. Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Bioduro-Sundia Main Business
Table 129. Bioduro-Sundia Latest Developments
Table 130. Allucent Details, Company Type, Drug Metabolism and Pharmacokinetics (DMPK) Area Served and Its Competitors
Table 131. Allucent Drug Metabolism and Pharmacokinetics (DMPK) Product Offered
Table 132. Allucent Drug Metabolism and Pharmacokinetics (DMPK) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Allucent Main Business
Table 134. Allucent Latest Developments



LIST OF FIGURES

Figure 1. Drug Metabolism and Pharmacokinetics (DMPK) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Drug Metabolism and Pharmacokinetics (DMPK) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Drug Metabolism and Pharmacokinetics (DMPK) Sales Market Share by Country/Region (2023)
Figure 8. Drug Metabolism and Pharmacokinetics (DMPK) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Type in 2023
Figure 10. Drug Metabolism and Pharmacokinetics (DMPK) in Biopharmaceutical Companies
Figure 11. Global Drug Metabolism and Pharmacokinetics (DMPK) Market: Biopharmaceutical Companies (2019-2024) & ($ millions)
Figure 12. Drug Metabolism and Pharmacokinetics (DMPK) in Government and Academic Institutes
Figure 13. Global Drug Metabolism and Pharmacokinetics (DMPK) Market: Government and Academic Institutes (2019-2024) & ($ millions)
Figure 14. Drug Metabolism and Pharmacokinetics (DMPK) in Others
Figure 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Market: Others (2019-2024) & ($ millions)
Figure 16. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Application in 2023
Figure 17. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Player in 2023
Figure 18. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Region (2019-2024)
Figure 19. Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2019-2024 ($ millions)
Figure 20. APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2019-2024 ($ millions)
Figure 21. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2019-2024 ($ millions)
Figure 23. Americas Drug Metabolism and Pharmacokinetics (DMPK) Value Market Share by Country in 2023
Figure 24. United States Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Region in 2023
Figure 29. APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Type (2019-2024)
Figure 30. APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Application (2019-2024)
Figure 31. China Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 35. India Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Country in 2023
Figure 38. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 41. France Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 54. APAC Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 55. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 57. United States Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 58. Canada Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 59. Mexico Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 60. Brazil Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 61. China Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 62. Japan Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 63. Korea Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 65. India Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 66. Australia Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 67. Germany Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 68. France Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 69. UK Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 70. Italy Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 71. Russia Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 72. Egypt Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 73. South Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 74. Israel Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 75. Turkey Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Drug Metabolism and Pharmacokinetics (DMPK) Market Size 2025-2030 ($ millions)
Figure 77. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Market Share Forecast by Application (2025-2030)


More Publications